Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SRTA · against 421 other Healthcare companies of similar size
Ranked #320 of 422 · scores higher than 24% of peers · safety percentile 27
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)35 peers with a safety percentile of 20–29, including SRTA · Click a bar to see the companies
Mainly because of its beta, which is weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | SRTA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 387 reported | 0.02× | 0.18× | 84% | 33% | |
| BetaLower is better · 407 reported | 2.26 | 0.45 | 3% | 33% | |
| Current ratioHigher is better · 414 reported | 2.64× | 2.90× | 46% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 421M USD | 99 | 52 | |
| 2 | 261M USD | 99 | 97 | |
| 3 | 397M USD | 99 | 37 | |
| 4 | 455M USD | 99 | 53 | |
| 5 | 2.7B CNY (≈$375M) | 99 | 67 | |
| 316 | 1.8B HKD (≈$236M) | 28 | ||
| 317 | 4.6B CNY (≈$646M) | 28 | 53 | |
| 318 | 655M AUD (≈$432M) | 28 | 62 | |
| 319 | 1.8B CNY (≈$255M) | 27 | 29 | |
| 320 | 393M USD | 27 | 61 | |
| 321 | 213M EUR (≈$235M) | 27 | 40 | |
| 322 | 384.1B KRW (≈$277M) | 27 | 40 | |
| 323 | 291M EUR (≈$320M) | 27 | 54 | |
| 324 | 287M CHF (≈$329M) | 27 | 47 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score